These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10273150)

  • 21. Peer review organizations expected to have major impact on UR.
    Hosp Peer Rev; 1982 Nov; 7(11):136-7. PubMed ID: 10273331
    [No Abstract]   [Full Text] [Related]  

  • 22. PROs and private review: proceed with caution!
    Becker RJ
    Internist; 1986 Jul; 27(6):17-8. PubMed ID: 10278603
    [No Abstract]   [Full Text] [Related]  

  • 23. PSRO: an evaluation of the Professional Standards Review Organization.
    J Medicaid Manage; 1977; 1(3):87-9. PubMed ID: 10308911
    [No Abstract]   [Full Text] [Related]  

  • 24. [FIGO guidelines for fetal monitoring].
    Stembera Z
    Cesk Gynekol; 1988 Jul; 53(6):462-9. PubMed ID: 3168013
    [No Abstract]   [Full Text] [Related]  

  • 25. Hospitals relinquish delegated review status.
    LaViolette S
    Mod Healthc; 1980 Jan; 10(1):54, 56. PubMed ID: 10273183
    [No Abstract]   [Full Text] [Related]  

  • 26. Corporations turn to PSROs.
    Snyder JD; Bale C
    Physicians Manage; 1979 Nov; 19(11):89, 93. PubMed ID: 10273171
    [No Abstract]   [Full Text] [Related]  

  • 27. Roundup: PSRO's grapple with review funds cut.
    Hosp Peer Rev; 1978 Nov; 3(11):148-50. PubMed ID: 10273107
    [No Abstract]   [Full Text] [Related]  

  • 28. Insurers can benefit from PSRO review.
    Myhre BC
    Natl Underwrit Life Health; 1980 Jun; 84(23):11-2. PubMed ID: 10273205
    [No Abstract]   [Full Text] [Related]  

  • 29. Peer review organizations: implications for discharge planning.
    Granitir T
    Disch Plann Update; 1985; 5(3):4-10. PubMed ID: 10273644
    [No Abstract]   [Full Text] [Related]  

  • 30. Utilization review--utility or futility?
    Korjus JH
    Am Arch Rehabil Ther; 1979; 27(3):23-6. PubMed ID: 10273215
    [No Abstract]   [Full Text] [Related]  

  • 31. New Medicare review system an option for private sector.
    Garrigan LA
    Bus Insur; 1986 Feb; 20(7):45-6. PubMed ID: 10324862
    [No Abstract]   [Full Text] [Related]  

  • 32. Government, PROs racing to implement tough review system.
    Wallace C
    Mod Healthc; 1984 Oct; 14(13):44-50. PubMed ID: 10299719
    [No Abstract]   [Full Text] [Related]  

  • 33. The new economics of PSRO review: an uncertain future.
    Luecke RW; Freeman JK
    Hosp Financ Manage; 1981 Apr; 35(4):56-8, 60, 62. PubMed ID: 10273247
    [No Abstract]   [Full Text] [Related]  

  • 34. Coping with cost reductions.
    Ankrum AD
    Hosp Peer Rev; 1978 Oct; 3(10):141. PubMed ID: 10273104
    [No Abstract]   [Full Text] [Related]  

  • 35. The economics of delegated vs. nondelegated PSRO review.
    Luecke RW
    Hosp Financ Manage; 1980 Jul; 34(7):24-30. PubMed ID: 10273228
    [No Abstract]   [Full Text] [Related]  

  • 36. PSRO reduces admissions for three procedures by half.
    Schlein P
    Hosp Peer Rev; 1979 Dec; 4(12):165-7. PubMed ID: 10325181
    [No Abstract]   [Full Text] [Related]  

  • 37. The new scope of work: what it means to PROs and providers.
    Siegel SH
    Healthc Financ Manage; 1986 Aug; 40(8):64-8. PubMed ID: 10277300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospital utilization review--an essential element in health care cost containment.
    Handel B
    Empl Benefits J; 1984 Sep; 9(3):8-12, 30. PubMed ID: 10273548
    [No Abstract]   [Full Text] [Related]  

  • 39. Going after favorable PRO determinations.
    Gosfield AG
    Cost Containment; 1985 Oct; 7(19):3-6. PubMed ID: 10273714
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical review organizations: a model state immunity statute.
    Kopit WG; Shapiro LE; Eaton KB
    Group Pract; 1980 Apr; 29(4):17-20. PubMed ID: 10273186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.